Gonadal Toxicity in Women With Hodgkin Lymphoma (FertHD)

Gruppo Italiano Studio Linfomi

Status: Unknown

Conditions: Hodgkin Lymphoma

Study type: Observational

Funder types: Other

Identifiers

NCT01008735

FertHD

Details and patient eligibility

About

The Gruppo Italiano Studio Linfomi has been collecting data on patients with Hodgkin Lymphoma (HL) since 1988. This archive represents a homogeneous series of consecutive patients with HL. The very long follow up and the availability of clinical and treatment data make it feasible to perform a study on the gonadal toxicity related to treatment for HL.

Enrollment: 150 estimated patients

Sex: Female

Ages: 18 to 40 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Female patients in complete remission after chemotherapy for Hodgkin lymphoma
• Age ≥ 18 e < 40 years
• Previous regular menstrual cycle
• No previous or concomitant gynecological diseases affecting reproducing function
• No other chemo-radiotherapy for other neoplasm
• Written informed consent

Exclusion criteria

• none

Trial design

150 participants in 1 patient group

women with hodgkin lymphoma treated with chemotherapy